Impact of contact force technology on atrial fibrillation ablation

A meta-analysis

Mohammed Shurrab, Luigi Di Biase, David F. Briceno, Anna Kaoutskaia, Saleem Haj-Yahia, David Newman, Ilan Lashevsky, Hiroshi Nakagawa, Eugene Crystal

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Background-Catheter-tissue contact is essential for effective lesion formation, thus there is growing usage of contact force (CF) technology in atrial fibrillation ablation. We conducted a meta-analysis to assess the impact of CF on clinical outcomes and procedural parameters in comparison to conventional catheter for atrial fibrillation ablation. Methods and Results-An electronic search was performed using major databases. Outcomes of interest were recurrence rate, major complications, total procedure, and fluoroscopic times. Continuous variables were reported as standardized mean difference; odds ratios were reported for dichotomous variables. Eleven studies (2 randomized controlled studies and 9 cohorts) involving 1428 adult patients were identified. CF was deployed in 552 patients. The range of CF used was between 2 to 60 gramforce. The follow-up period ranged between 10 and 53 weeks. In comparing CF and conventional catheter groups, the recurrence rate was lower with CF (35.1% versus 45.5%, odds ratio 0.62 [95% CI 0.45-0.86], P=0.004). Shorter procedure and fluoroscopic times were achieved with CF (procedure time: 156 versus 173 minutes, standardized mean difference -0.85 [95% CI -1.48 to -0.21], P=0.009; fluoroscopic time: 28 versus 36 minutes, standardized mean difference -0.94 [95% CI -1.66; -0.21], P=0.01). Major complication rate was lower numerically in the CF group but not statistically significant (1.3% versus 1.9%, odds ratio 0.71 [95% CI 0.29-1.73], P=0.45). Conclusions-The use of CF technology results in significant reduction of the atrial fibrillation recurrence rate after atrial fibrillation ablation in comparison to the conventional catheter group. CF technology is able to significantly reduce procedure and fluoroscopic times without compromising complication rate.

Original languageEnglish (US)
Article numbere002476
JournalJournal of the American Heart Association
Volume4
Issue number9
DOIs
StatePublished - Sep 1 2015

Fingerprint

Atrial Fibrillation
Meta-Analysis
Technology
Catheters
Odds Ratio
Recurrence
Cohort Studies
Databases

Keywords

  • Ablation
  • Atrial fibrillation
  • Contact force
  • Meta-analysis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Impact of contact force technology on atrial fibrillation ablation : A meta-analysis. / Shurrab, Mohammed; Di Biase, Luigi; Briceno, David F.; Kaoutskaia, Anna; Haj-Yahia, Saleem; Newman, David; Lashevsky, Ilan; Nakagawa, Hiroshi; Crystal, Eugene.

In: Journal of the American Heart Association, Vol. 4, No. 9, e002476, 01.09.2015.

Research output: Contribution to journalArticle

Shurrab, M, Di Biase, L, Briceno, DF, Kaoutskaia, A, Haj-Yahia, S, Newman, D, Lashevsky, I, Nakagawa, H & Crystal, E 2015, 'Impact of contact force technology on atrial fibrillation ablation: A meta-analysis', Journal of the American Heart Association, vol. 4, no. 9, e002476. https://doi.org/10.1161/JAHA.115.002476
Shurrab, Mohammed ; Di Biase, Luigi ; Briceno, David F. ; Kaoutskaia, Anna ; Haj-Yahia, Saleem ; Newman, David ; Lashevsky, Ilan ; Nakagawa, Hiroshi ; Crystal, Eugene. / Impact of contact force technology on atrial fibrillation ablation : A meta-analysis. In: Journal of the American Heart Association. 2015 ; Vol. 4, No. 9.
@article{019998f269bc46cab601a3901d83e9d7,
title = "Impact of contact force technology on atrial fibrillation ablation: A meta-analysis",
abstract = "Background-Catheter-tissue contact is essential for effective lesion formation, thus there is growing usage of contact force (CF) technology in atrial fibrillation ablation. We conducted a meta-analysis to assess the impact of CF on clinical outcomes and procedural parameters in comparison to conventional catheter for atrial fibrillation ablation. Methods and Results-An electronic search was performed using major databases. Outcomes of interest were recurrence rate, major complications, total procedure, and fluoroscopic times. Continuous variables were reported as standardized mean difference; odds ratios were reported for dichotomous variables. Eleven studies (2 randomized controlled studies and 9 cohorts) involving 1428 adult patients were identified. CF was deployed in 552 patients. The range of CF used was between 2 to 60 gramforce. The follow-up period ranged between 10 and 53 weeks. In comparing CF and conventional catheter groups, the recurrence rate was lower with CF (35.1{\%} versus 45.5{\%}, odds ratio 0.62 [95{\%} CI 0.45-0.86], P=0.004). Shorter procedure and fluoroscopic times were achieved with CF (procedure time: 156 versus 173 minutes, standardized mean difference -0.85 [95{\%} CI -1.48 to -0.21], P=0.009; fluoroscopic time: 28 versus 36 minutes, standardized mean difference -0.94 [95{\%} CI -1.66; -0.21], P=0.01). Major complication rate was lower numerically in the CF group but not statistically significant (1.3{\%} versus 1.9{\%}, odds ratio 0.71 [95{\%} CI 0.29-1.73], P=0.45). Conclusions-The use of CF technology results in significant reduction of the atrial fibrillation recurrence rate after atrial fibrillation ablation in comparison to the conventional catheter group. CF technology is able to significantly reduce procedure and fluoroscopic times without compromising complication rate.",
keywords = "Ablation, Atrial fibrillation, Contact force, Meta-analysis",
author = "Mohammed Shurrab and {Di Biase}, Luigi and Briceno, {David F.} and Anna Kaoutskaia and Saleem Haj-Yahia and David Newman and Ilan Lashevsky and Hiroshi Nakagawa and Eugene Crystal",
year = "2015",
month = "9",
day = "1",
doi = "10.1161/JAHA.115.002476",
language = "English (US)",
volume = "4",
journal = "Journal of the American Heart Association",
issn = "2047-9980",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - Impact of contact force technology on atrial fibrillation ablation

T2 - A meta-analysis

AU - Shurrab, Mohammed

AU - Di Biase, Luigi

AU - Briceno, David F.

AU - Kaoutskaia, Anna

AU - Haj-Yahia, Saleem

AU - Newman, David

AU - Lashevsky, Ilan

AU - Nakagawa, Hiroshi

AU - Crystal, Eugene

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Background-Catheter-tissue contact is essential for effective lesion formation, thus there is growing usage of contact force (CF) technology in atrial fibrillation ablation. We conducted a meta-analysis to assess the impact of CF on clinical outcomes and procedural parameters in comparison to conventional catheter for atrial fibrillation ablation. Methods and Results-An electronic search was performed using major databases. Outcomes of interest were recurrence rate, major complications, total procedure, and fluoroscopic times. Continuous variables were reported as standardized mean difference; odds ratios were reported for dichotomous variables. Eleven studies (2 randomized controlled studies and 9 cohorts) involving 1428 adult patients were identified. CF was deployed in 552 patients. The range of CF used was between 2 to 60 gramforce. The follow-up period ranged between 10 and 53 weeks. In comparing CF and conventional catheter groups, the recurrence rate was lower with CF (35.1% versus 45.5%, odds ratio 0.62 [95% CI 0.45-0.86], P=0.004). Shorter procedure and fluoroscopic times were achieved with CF (procedure time: 156 versus 173 minutes, standardized mean difference -0.85 [95% CI -1.48 to -0.21], P=0.009; fluoroscopic time: 28 versus 36 minutes, standardized mean difference -0.94 [95% CI -1.66; -0.21], P=0.01). Major complication rate was lower numerically in the CF group but not statistically significant (1.3% versus 1.9%, odds ratio 0.71 [95% CI 0.29-1.73], P=0.45). Conclusions-The use of CF technology results in significant reduction of the atrial fibrillation recurrence rate after atrial fibrillation ablation in comparison to the conventional catheter group. CF technology is able to significantly reduce procedure and fluoroscopic times without compromising complication rate.

AB - Background-Catheter-tissue contact is essential for effective lesion formation, thus there is growing usage of contact force (CF) technology in atrial fibrillation ablation. We conducted a meta-analysis to assess the impact of CF on clinical outcomes and procedural parameters in comparison to conventional catheter for atrial fibrillation ablation. Methods and Results-An electronic search was performed using major databases. Outcomes of interest were recurrence rate, major complications, total procedure, and fluoroscopic times. Continuous variables were reported as standardized mean difference; odds ratios were reported for dichotomous variables. Eleven studies (2 randomized controlled studies and 9 cohorts) involving 1428 adult patients were identified. CF was deployed in 552 patients. The range of CF used was between 2 to 60 gramforce. The follow-up period ranged between 10 and 53 weeks. In comparing CF and conventional catheter groups, the recurrence rate was lower with CF (35.1% versus 45.5%, odds ratio 0.62 [95% CI 0.45-0.86], P=0.004). Shorter procedure and fluoroscopic times were achieved with CF (procedure time: 156 versus 173 minutes, standardized mean difference -0.85 [95% CI -1.48 to -0.21], P=0.009; fluoroscopic time: 28 versus 36 minutes, standardized mean difference -0.94 [95% CI -1.66; -0.21], P=0.01). Major complication rate was lower numerically in the CF group but not statistically significant (1.3% versus 1.9%, odds ratio 0.71 [95% CI 0.29-1.73], P=0.45). Conclusions-The use of CF technology results in significant reduction of the atrial fibrillation recurrence rate after atrial fibrillation ablation in comparison to the conventional catheter group. CF technology is able to significantly reduce procedure and fluoroscopic times without compromising complication rate.

KW - Ablation

KW - Atrial fibrillation

KW - Contact force

KW - Meta-analysis

UR - http://www.scopus.com/inward/record.url?scp=85006228129&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006228129&partnerID=8YFLogxK

U2 - 10.1161/JAHA.115.002476

DO - 10.1161/JAHA.115.002476

M3 - Article

VL - 4

JO - Journal of the American Heart Association

JF - Journal of the American Heart Association

SN - 2047-9980

IS - 9

M1 - e002476

ER -